Denali Therapeutics Inc (DNLI)

Aug 12, 2025

DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26 - Yahoo Finance

Aug 12, 2025

Aug 11, 2025

Denali Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 11, 2025

Aug 11, 2025

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

Aug 11, 2025

Aug 11, 2025

FDA Fast-Tracks Denali's Breakthrough Hunter Syndrome Drug as Pipeline Expands - Stock Titan

Aug 11, 2025

Aug 10, 2025

Possible Bearish Signals With Denali Therapeutics Insiders Disposing Stock - 富途牛牛

Aug 10, 2025

Aug 07, 2025

BTIG Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

Aug 07, 2025

Aug 04, 2025

Is Denali Therapeutics Inc. a good long term investmentMaster stock selection with insider knowledge - Jammu Links News

Aug 04, 2025

Aug 03, 2025

How strong is Denali Therapeutics Inc. company’s balance sheetCapitalize on momentum stocks before they peak - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Denali Therapeutics Inc. company’s key revenue driversInvest smarter with daily market updates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Denali Therapeutics Inc. stockFree Technical Analysis Support - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is Denali Therapeutics Inc. company’s growth strategyConsistent triple-digit returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Denali Therapeutics Inc. stock overvalued or undervaluedAchieve unparalleled market performance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Denali Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert trading strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Denali Therapeutics Inc. generate profit in a changing economyMarket-leading profit generation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Denali Therapeutics Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is Denali Therapeutics Inc. stock compared to the marketFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What is the risk reward ratio of investing in Denali Therapeutics Inc. stockSky-high return potential - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Denali Therapeutics Inc. a growth stock or a value stockAccelerated financial growth - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What are analysts’ price targets for Denali Therapeutics Inc. in the next 12 monthsInvest smarter with cutting-edge analytics - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is it the right time to buy Denali Therapeutics Inc. stockTransform your portfolio with high-yield stocks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation - MSN

Aug 02, 2025

Jul 31, 2025

Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - Insider Monkey

Jul 31, 2025

Jul 30, 2025

Price momentum metrics for Denali Therapeutics Inc. explainedStock Portfolio Allocation Guidance for Volatile Markets - metal.it

Jul 30, 2025

Jul 30, 2025

11 Best Future Stocks to Buy Now - Insider Monkey

Jul 30, 2025

Jul 30, 2025

Biogen’s BIIB122 Study: A New Hope for LRRK2-Associated Parkinson’s Disease - TipRanks

Jul 30, 2025

Jul 29, 2025

Can Denali Therapeutics Inc. Rally Enough to Break EvenReal Profit Trade Plan Suggestions Shared Widely - metal.it

Jul 29, 2025

Jul 29, 2025

Volume Surge May Signal Institutional Interest in Denali Therapeutics Inc.Trade Setups With Clear Risk Limits Highlighted - metal.it

Jul 29, 2025

Jul 28, 2025

What are the technical indicators suggesting about Denali Therapeutics Inc.Real Time Guidance For 2025 - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Published on: 2025-07-28 03:16:35 - Jammu Links News

Jul 27, 2025

Jul 27, 2025

Published on: 2025-07-27 16:21:55 - Jammu Links News

Jul 27, 2025

Jul 26, 2025

BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN

Jul 26, 2025